Copper as the Target for Anticancer Nanomedicine-Reference-Cited by-同舟云学术

Copper as the Target for Anticancer Nanomedicine

Published:2019-02-21 Issue:5 Volume:2 Page:1800147
ISSN:2366-3987
Container-title:Advanced Therapeutics
language:en
Short-container-title:Adv. Therap.

Author:

Shao Shiqun¹,Si Jingxing²,Shen Youqing¹^ORCID

Affiliation:

1. Center for Bionanoengineering and Key Laboratory of Biomass Chemical Engineering of Ministry of EducationCollege of Chemical and Biological Engineering, Zhejiang University Hangzhou 310027 China

2. Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang ProvinceClinical Research Institute, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College Hangzhou 310014 China

Funder

National Basic Research Program of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology (medical),Biochemistry, medical,Genetics(clinical),Pharmaceutical Science,Pharmacology,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adtp.201800147

Reference144 articles.

1. Elevated copper and oxidative stress in cancer cells as a target for cancer treatment

2. Copper levels in patients with hematological malignancies

3. Angiogenesis and Cancer Control: From Concept to Therapeutic Trial

4. Localization of Tissue Copper in Mouse Mammary Tumors

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor vasculature associated nanomedicine strategies;Coordination Chemistry Reviews;2024-12

2. Metal-organic frameworks in oral drug delivery;Asian Journal of Pharmaceutical Sciences;2024-08

3. Biochemical Behavior, Influence on Cell DNA Condition, and Microbiological Properties of Wool and Wool–Copper Materials;Materials;2024-06-12

4. Intelligent nanoreactor coupling tumor microenvironment manipulation and H2O2-dependent photothermal-chemodynamic therapy for accurate treatment of primary and metastatic tumors;Bioactive Materials;2024-04

5. Unveiling the mechanisms and challenges of cancer drug resistance;Cell Communication and Signaling;2024-02-12